O
PYXS icon

OrbiMed’s Pyxis Oncology PYXS Stock Holding History

OrbiMed’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-848,252
Closed -$1.14M – 136
2022
Q4 		$1.14M Hold
848,252
– – 0.02% 107
2022
Q3 		$1.67K Buy
+848,252
New +$2.22M 0.03% 122
2022
Q2 		– Sell
-143,640
Closed -$580K – 149
2022
Q1 		$580K Hold
143,640
– – 0.01% 141
2021
Q4 		$1.58M Buy
+143,640
New +$1.64M 0.02% 153

Other funds holding PYXS

LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

OrbiMed's PYXS Position: Q1 2023 in Review

OrbiMed sold out of Pyxis Oncology (PYXS) in Q1 2023, closing a stake of 848,252 shares — an estimated $1.14M sold.

OrbiMed first reported a position in PYXS in Q4 2021 and held it in 4 quarters. The position peaked at $1.58M in Q4 2021. 47 funds tracked by Wall St. Rank hold PYXS as of Q1 2023.

  • OrbiMed reported no remaining Pyxis Oncology position as of Q1 2023 after selling out during the quarter.
  • OrbiMed sold 848,252 Pyxis Oncology shares in Q1 2023, an estimated $1.14M.
  • OrbiMed first reported a position in Pyxis Oncology in Q4 2021 and held it in 4 quarters.
  • OrbiMed's Pyxis Oncology position peaked at $1.58M in Q4 2021.
  • 47 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2023.

Based on OrbiMed's 13F filing for Q1 2023, filed 15 May 2023.